Development and validation of an enantioselective LC–MS/MS method for the analysis of the anthelmintic drug praziquantel and its main metabolite in human plasma, blood and dried blood spots
- 1 January 2016
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 118, 81-88
Abstract
No abstract availableKeywords
Funding Information
- European Research Council
This publication has 20 references indexed in Scilit:
- Merck’s Perspective on The Implementation of Dried Blood Spot Technology in Clinical Drug Development – Why, When and HowBioanalysis, 2013
- Modulation of expression and activity of cytochrome P450s and alteration of praziquantel kinetics during murine schistosomiasisMemórias do Instituto Oswaldo Cruz, 2011
- Pharmacokinetic Considerations as to When to Use Dried Blood Spot SamplingBioanalysis, 2010
- Dried Blood Spots as a Sample Collection Technique for the Determination of Pharmacokinetics in Clinical Studies: Considerations for the Validation of a Quantitative Bioanalytical MethodAnalytical Chemistry, 2009
- Biomimetic oxidation of praziquantel catalysed by metalloporphyrinsJournal of Molecular Catalysis A: Chemical, 2005
- Identification of human cytochrome P 450 s that metabolise anti-parasitic drugs and predictions of in vivo drug hepatic clearance from in vitro dataEuropean Journal of Clinical Pharmacology, 2003
- Investigation of Praziquantel metabolism in isolated rat hepatocytesJournal of Pharmaceutical and Biomedical Analysis, 2001
- Bioavailability of Praziquantel Increases with Concomitant Administration of FoodAntimicrobial Agents and Chemotherapy, 2000
- Investigation of the stereoselective metabolism of praziquantel after incubation with rat liver microsomes by capillary electrophoresis and liquid chromatography–mass spectrometryJournal of Chromatography B: Biomedical Sciences and Applications, 1998
- Liquid chromatographic separation of praziquantel enantiomers in serum using a cellulose-based chiral stationary phaseJournal of Pharmaceutical and Biomedical Analysis, 1993